Latest Tysabri news
Enhanced Atypical Lymphocytes in Natalizumab-Treated MS
posted May 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with relapsing-remitting multiple sclerosis, natalizumab treatment is associated with enhancement of atypical lymphocytes, especially binucleated and plasmacytoid lymphocytes, according to a study published online May 8 in the International Journal of Laboratory Hematology.
Tysabri Impacts Seroconversion in John Cunningham Virus
posted January 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with John Cunningham virus (JCV), natalizumab (Tysabri) treatment affects seroconversion and JCV index values, according to a study published online Jan. 27 in Neurology: Neuroimmunology & Neuroinflammation.
1 in 4 Former NFL Players Had CTE at Death in 2016 to 2021 
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy 
Frequent TV Watching Linked to Smaller Brain Volume 
ADHD Poses Additional Concussion Challenges for Athletes 
Extreme Heat Linked to 33 Clinically Reportable Diagnoses 
Problematic Social Media Use Linked to Worsening of ADHD Symptoms 
High Levels of Light Exposure Linked to Lower Dementia Risk .jpeg)
Neurodegenerative Mortality Elevated for NFL Athletes Monthly Specialist Briefings
Stay Connected
